Connection
Jawahar Mehta to Cause of Death
This is a "connection" page, showing publications Jawahar Mehta has written about Cause of Death.
|
|
Connection Strength |
|
|
|
|
|
1.117 |
|
|
|
-
Shoar S, Hosseini F, Naderan M, Mehta JL. Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19. Am J Cardiol. 2020 11 15; 135:50-61.
Score: 0.686
-
Abualsuod A, Rutland JJ, Watts TE, Pandat S, Delongchamp R, Mehta JL. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther. 2015 Jun; 29(3):265-75.
Score: 0.119
-
Mehta P, Mehta JL. Do we know why deaths from heart disease have declined? Am J Cardiol. 2014 Nov 15; 114(10):1627.
Score: 0.113
-
Balamurugan A, Mehta P, Bates J, Mehta JL. Change in mortality from coronary heart disease and stroke in Arkansas (1979 to 2007). Am J Cardiol. 2011 Jan 15; 107(2):156-60.
Score: 0.088
-
Sukhija R, Aronow WS, Sureddi R, Aleti S, Molavi B, Sachdeva R, Mehta JL. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol. 2007 Sep 01; 100(5):777-80.
Score: 0.068
-
Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. Am Heart J. 2021 03; 233:86-91.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|